Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · CTS (CTS)

CTS Q4 sales rise 2% to $127 million; full-year sales fall 6% to $516 million

Mixed Impact 3 of 5 earnings Written later

CTS Corporation reported fourth-quarter and full-year 2024 results on February 4, 2025. Q4 sales rose 2% to $127 million, but GAAP diluted EPS fell to $0.45 from $0.49, while adjusted diluted EPS rose to $0.53 from $0.47. For 2025, the company expects sales of $520 million to $550 million and adjusted diluted EPS of $2.20 to $2.35, compared with 2024 adjusted EPS of $2.17.

Key points

  • Q4 2024 sales were $127 million, up 2% year over year; the SyQwest acquisition added $11 million.
  • Full-year 2024 sales were $516 million, down 6%; full-year diluted EPS was $1.89 versus $1.92 in 2023.
  • Full-year 2024 operating cash flow was $99 million, up from $89 million in 2023.
  • 2025 guidance: sales of $520 million to $550 million and adjusted diluted EPS of $2.20 to $2.35.

The filing

CompanyCTS (CTS)
Form8-K, current report
Filed with the SECFeb 4, 2025, 8:00 AM ET
Accession number0000950170-25-012851

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:57 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 04, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.